» Authors » M Tardy-Panit

M Tardy-Panit

Explore the profile of M Tardy-Panit including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 137
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Merten O, Kallel H, Manuguerra J, Tardy-Panit M, Crainic R, Delpeyroux F, et al.
Cytotechnology . 2008 Nov; 30(1-3):191-201. PMID: 19003369
The development of media free of serum and animal or human proteins is of utmost importance for increasing the safety of biologicals produced for therapy and vaccination. In order to...
2.
Crainic R, Wu R, Otelea D, Georgescu M, Delpeyroux F, Guillot S, et al.
Dev Biol Stand . 1996 Jan; 87:161-6. PMID: 8854013
The poliomyelitis eradication programme relies largely on the massive administration of the oral poliovirus vaccine (OPV). The major difficulty in assuring good vaccine coverage, especially in hot climates, is the...
3.
Georgescu M, Tardy-Panit M, Guillot S, Crainic R, Delpeyroux F
J Virol . 1995 Sep; 69(9):5278-86. PMID: 7636970
The temperature-sensitive and attenuated phenotypes of the Sabin type 1 vaccine strain of poliovirus result from numerous point mutations which occurred in the virulent Mahoney virus parent. One of these...
4.
Georgescu M, Delpeyroux F, Tardy-Panit M, Balanant J, Combiescu M, Combiescu A, et al.
J Virol . 1994 Dec; 68(12):8089-101. PMID: 7966599
To establish the etiology of vaccine-associated paralytic poliomyelitis (VAPP), isolates from the central nervous system (CNS) from eight patients with VAPP were compared with stool isolates from the same patients....
5.
Tardy-Panit M, Blondel B, Martin A, Tekaia F, Horaud F, Delpeyroux F
J Virol . 1993 Aug; 67(8):4630-8. PMID: 8392604
The attenuated Sabin strain of poliovirus type 1 (PV-1) differs from the neurovirulent PV-1 Mahoney strain by 55 nucleotide mutations. Only one of these mutations (A-480-->G, in the 5' noncoding...
6.
Michelson S, Tardy-Panit M, Colimon R, Landini M
J Gen Virol . 1989 Mar; 70 ( Pt 3):673-84. PMID: 2471796
A monoclonal antibody (MAb), N2, neutralized human cytomegalovirus (HCMV) infectivity in the absence of complement and recognized a normal cell protein. By immunofluorescence, MAb N2 detected antigens in uninfected human...
7.
Michelson S, Tardy-Panit M, Barzu O
Eur J Biochem . 1985 Jun; 149(2):393-9. PMID: 2986975
Human cytomegalovirus, a DNA virus whose genome contains a fragment of transforming DNA, induces a threonine-serine protein kinase having a molecular mass of 68 kDa (p68). p68 was extracted from...
8.
Michelson S, Tardy-Panit M, Barzu O
Virology . 1984 Apr; 134(2):259-68. PMID: 6100570
A human cytomegalovirus (HCMV)-induced polypeptide of 68,000 Da (p68) with protein kinase activity was identified using a monoclonal antibody (F6b) produced against HCMV-infected cell proteins. p68 was detected by immunoprecipitation...
9.
Tardy-Panit M, Michelson S, HORODNICEANU F
J Clin Microbiol . 1980 Jun; 11(6):717-9. PMID: 6253519
An immunofluorescence technique is described which permits the elimination of nonspecific cytoplasmic staining from late antigen preparations by using in situ a buffer containing Nonidet P-40.
10.
Michelson S, HORODNICEANU F, Kress M, Tardy-Panit M
J Virol . 1979 Oct; 32(1):259-67. PMID: 232177
Immediate early antigen (IEA) induced in human lung fibroblasts by human cytomegalovirus was characterized by sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis after immunoprecipitation with IEA-positive human sera. Two polypeptides of...